Genetic testing for von Willebrand disease: the case for.
Peake
I R
IR
Sheffield Haemostasis Research Group, Department of Cardiovascular Science, University of Sheffield Faculty of Medicine, Dentistry & Health, Sheffield, UK. i.r.peake@shef.ac.uk
Goodeve
A C
AC
D003362:Cost-Benefit Analysis; D004252:DNA Mutational Analysis / Q000191:economics; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000191:economics / Q000379:methods* / Q000458:organization & administration; D006801:Humans; D009154:Mutation; D010641:Phenotype; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D014842:von Willebrand Diseases / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D014841:von Willebrand Factor / Q000235:genetics* / Q000378:metabolism
D014841:von Willebrand Factor